Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine for acute pain in adult emergency department patients
ACTRN12611001102965Phase 4Completed
- Sponsor
- SouthernBiotech
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ketamine in acute pain, sponsored by SouthernBiotech. Primary endpoint: Mean change in Visual Analog Scale pain score from baseline to 30 minutes. Started Dec 2012; status: completed.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on ACTRN12611001102965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001102965.